Honorary Fellowship – Queens’ College, University of Cambridge  

In December 2024, Kelly Chibale was elected and admitted as an Honorary Fellow of Queens’ College, University of Cambridge – his alma mater where he completed his PhD in Chemistry. This is the highest honour the College can bestow on an individual, reflecting their exceptional achievements and contributions.

As noted by the President of Queens’ College, Dr Mohamed A. El-Erian: “This is the highest honour that we, as a College, can bestow and reflects our admiration for you as a person and your wonderful achievements to date.”

Kelly’s Fellowship was officially conferred on 13 December 2024, a moment celebrated in write-ups by both Queens’ College and the Yusuf Hamied Department of Chemistry, where he pursued his doctoral studies.

Kelly Chibale Elected to United States National Academy of Medicine (NAM)

Kelly Chibale, PhD, has been elected as one of the 10 international members of the prestigious United States National Academy of Medicine (NAM). This honour recognises Kelly’s pioneering work in drug discovery and development, particularly in tackling infectious diseases on the African continent.

Kelly’s election to NAM highlights his leadership in global health and his exceptional contributions to advancing medical science in Africa. Notably, he has led international teams to discover the first small molecule clinical candidate researched on African soil by an African-led team. This recognition is a testament to Kelly’s unwavering commitment to improving health outcomes and fostering scientific innovation.

Kelly extends his heartfelt gratitude to his academic group, H3D team members – past and present – as well as his research collaborators and funders for their invaluable support in achieving this milestone.

Full press release here: https://nam.edu/national-academy-of-medicine-elects-100-new-members-2024/

Catch Up With The Latest On

Kelly Chibale

Find the latest news, interviews, podcasts and developments related to Kelly Chibale here.

Africa holds the key to future drug research

Watch now:

In collaboration with AI2050 and Schmidt Sciences, I’m excited to share this film where I discuss how AI is helping us leapfrog barriers in drug discovery and tailoring medicines for the diverse genetic makeup of African populations.